Loss Per Share The following table sets forth the computation of basic and diluted loss per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
(in thousands, except per share data) |
2025 |
|
2024 |
|
|
|
|
Numerator: |
|
|
|
|
|
|
|
Net loss from continuing operations |
$ |
(1,002) |
|
|
$ |
(3,766) |
|
|
|
|
|
Net loss from discontinued operations |
$ |
(1,291) |
|
|
$ |
(1,727) |
|
|
|
|
|
Net loss |
$ |
(2,293) |
|
|
$ |
(5,493) |
|
|
|
|
|
Denominator: |
|
|
|
|
|
|
|
Weighted-average common shares outstanding |
10,076 |
|
|
10,094 |
|
|
|
|
|
Effect of dilutive securities: |
|
|
|
|
|
|
|
Employee stock options and stock grants |
— |
|
|
— |
|
|
|
|
|
Weighted-average common shares, as adjusted |
10,076 |
|
|
10,094 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share from continuing operations: |
|
|
|
|
|
|
|
Basic |
$ |
(0.10) |
|
|
$ |
(0.37) |
|
|
|
|
|
Diluted |
$ |
(0.10) |
|
|
$ |
(0.37) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share from discontinued operations: |
|
|
|
|
|
|
|
Basic |
$ |
(0.13) |
|
|
$ |
(0.17) |
|
|
|
|
|
Diluted |
$ |
(0.13) |
|
|
$ |
(0.17) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share: |
|
|
|
|
|
|
|
Basic |
$ |
(0.23) |
|
|
$ |
(0.54) |
|
|
|
|
|
Diluted |
$ |
(0.23) |
|
|
$ |
(0.54) |
|
|
|
|
|
The diluted earnings (loss) per share calculations exclude the effect of potentially dilutive shares when the inclusion of those shares in the calculation would have an anti-dilutive effect. The Company had $0.1 million shares that were anti-dilutive for the three months ended March 31, 2025 and 2024, respectively.
|